Doctor Robyn Bryde

St. Luke's, Boise (United States of America)

Follow

Contributor content

Concurrent management of DKA from SGLT2 inhibitor therapy and acute decompensated heart failure

Presentation

Concurrent management of DKA from SGLT2 inhibitor therapy and acute decompensated heart failure

ESC 365 is supported by

novartis

Explore sponsored resources